MedTrace Logo

Leadership ThriveCircles

NCT07435753 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2026-03-05

No results posted yet for this study

Summary

This study aims to strengthen leadership competencies among CU SOM faculty who have at least five direct reports by promoting meaningful behavior change in leadership practices and fostering a culture of peer support, to advance employee well-being and help reduce burnout among healthcare professionals. 125 leaders will take part in a six-month leadership development program consisting of 6 self-paced learning focus areas and 6 in-person sessions with peers to discuss. The investigators will evaluate the program's implementation process and its effectiveness in achieving desired outcomes.

Conditions

  • Burnout
  • Professional Fulfillment
  • Belonging
  • Intent to Leave
  • Leadership

Interventions

BEHAVIORAL

CU Thrive Leadership Circles

The CU SOM leadership program is based on the Wellness-Centered Leadership framework and Mayo Clinic Leadership Index behaviors, using a COMPASS-style peer group model to build leadership skills and community. Leaders complete brief pre-work and on-the-job practice challenges delivered through an online dashboard, then participate in facilitated peer sessions to discuss implementation successes and barriers. Sessions are led by trained leader-facilitators, with researchers not present, and include structured agendas to support consistent implementation and skill development.

Sponsors & Collaborators

  • CU Thrive: Office for Well-being | Center for Workplace Well-being Research

    collaborator UNKNOWN

  • University of Colorado, Denver

    collaborator OTHER

  • Colorado School of Public Health

    lead OTHER

Principal Investigators

  • Natalie V Schwatka, PhD MS · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07435753 on ClinicalTrials.gov